Cardiomatics

What Cardiomatics does

Cardiomatics spółka z ograniczoną odpowiedzialnością is a privately held Polish medical software company founded in 2017 and headquartered in Kraków, Poland. It builds a cloud-based, browser-delivered AI platform for analyzing Ambulatory (Holter) ECG recordings, with algorithms trained on over 8 million hours of ECG data and certified under EU MDR, CE, and Australian TGA frameworks. The platform targets cardiac clinics, hospital cardiology departments, general practitioners, and channel partners/distributors of Holter recording hardware, with named users including CardioParc (France), Kardiologie Interlaken (Switzerland), American Heart of Poland, Poliklinika Kardiologiczna Serce, University Hospital Basel, Medical University of Warsaw, and Weill Cornell Medicine.

Name

Cardiomatics

Legal name

Cardiomatics spółka z ograniczoną odpowiedzialnością

Website

https://cardiomatics.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Cardiomatics is a Poland-based medical software company (founded 2017) that provides a cloud-based, MDR-certified AI platform for analyzing Holter ECG recordings, serving cardiac clinics, hospitals, GPs, and Holter device distributors across 15+ countries.

Ownership category

akta.pro rank

Product category

AI-powered cardiac diagnostics software

akta.pro primary industry

Cardiac Monitoring (ECG/Holter/Event/Patch, Loop Recorders) (HLAHACAB)

akta.pro secondary industries

Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA), Cardiology Telemedicine Platforms (HLALAGAB)

Keywords

• AI ECG analysis
• Holter monitoring software
• Cardiac arrhythmia detection
• Ambulatory ECG reporting
• Medical device software

Headquarters

HQ city

Kraków

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Infrastructure, Marketing or Sales, Operations

Revenue model

1. Subscription-based ECG Analysis Reports: Cardiomatics generates recurring revenue through volume-based subscription plans (Core, Plus, Enterprise tiers). Customers purchase a monthly allocation of report credits. Credits are consumed per ECG analysis based on signal length: 1 credit for 0-48H recordings, 2 credits for up to 4 days, 3 credits for up to 7 days, and 4 credits for recordings over 7 days. Unused credits roll over to the next month. Subscriptions are available as 1-year or 3-year contracts. Volume-based pricing means higher monthly volume and longer contract terms result in lower per-report cost.
2. Prepaid Report Credits: Cardiomatics offers a prepaid report credit model as an alternative to subscription. Customers purchase credits in advance at defined rates, providing flexibility for lower-volume or intermittent usage patterns.
3. Extended Service Options: Optional premium services including Fast-Track 90-minute analysis delivery, Saturday quality assurance (extended service level), and custom branding on the web application and reports. These add-on services generate incremental revenue on top of base subscriptions.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Core offering

Cardiomatics is a CE/MDR-certified, cloud-based AI medical software platform for analyzing Ambulatory (Holter) ECG tests. It uses clinically validated machine learning algorithms trained on over 8 million hours of Holter ECG data to detect 20+ arrhythmias and cardiac events, generating PDF reports accessible entirely through a web browser. The platform is sold via Core, Plus, and Enterprise subscriptions with credit-based usage and optional add-ons such as Fast-Track 90-minute analysis and specialist Report Review, and is compatible with 60+ Holter ECG devices.

Product overview

Cardiomatics is a cloud-based AI medical software platform for analyzing Ambulatory (Holter) ECG tests. The product portfolio consists of a unified cloud platform with three subscription tiers (Core, Plus, Enterprise), enhanced by optional add-on services such as Fast-Track 90-minute expedited analysis and Report Review for cardiologist verification. The platform is accessible entirely via web browser with no installation required. Cardiomatics v5 represents the core software with the world's first MDR certification for AI-powered ECG interpretation. Cardiomatics Academy provides complementary free educational access for universities. The platform integrates with over 60 different Holter ECG recording devices from manufacturers worldwide, supporting data export for AI analysis.

Differentiator

Problem solved

Functional benefit

Products and services

• Cardiomatics Cloud Platform (Core, Plus and Enterprise subscriptions) Cloud-based, CE/MDR-certified AI software for analyzing Ambulatory (Holter) ECG tests, sold as three subscription tiers (Core: minimum 10 reports/month, up to 7-day signal length, 3-year storage; Plus: minimum 20 reports/month, up to 14-day signal length, unlimited storage, API access; Enterprise: minimum 500 reports/month, custom pricing and features). It is used by cardiologists, cardiac clinics, hospitals, GPs, and research institutions to detect 20+ arrhythmias and cardiac events and produce PDF clinical reports.
• Fast-Track 90-minute Analysis Service Premium expedited ECG analysis add-on that delivers AI-powered Holter ECG reports within 90 minutes, designed for urgent or time-sensitive clinical scenarios that cannot wait for the standard turnaround.
• Report Review Service
• Cardiomatics Academy
• Cardiomatics v5 Software Release Major version release of the Cardiomatics platform representing the world's first MDR-certified AI ECG interpretation software, with AV block detection, faster analysis, and a redesigned clinical report layout, achieving 0.998 Pearson correlation with manual physician evaluation in clinical validation.
• 2025 Platform Refresh Major platform refresh of the Cardiomatics Cloud in 2025 delivering smarter AI algorithms, faster performance, and a renewed user interface providing easier access to key clinical information, built jointly by the product, development, and clinical teams.

Quantifiable outcome

• 80% reduction in time spent on Holter ECG analysis
• +9 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration25 records

AI capability5 records

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Arseus MedicalcoreChannel Partner/ Reseller/ Distributor · 27 June 2025Cardiomatics partnered with Arseus Medical, a leading distributor of medical technology in the Benelux region (Belgium, Netherlands, Luxembourg), to bring AI-powered ECG analysis to cardiology clinics in those countries. Under the partnership, Arseus Medical distributes Cardiomatics alongside its existing Holter recorder portfolio (including Schiller devices), offering a comprehensive integrated cardiac diagnostic solution. Arseus provides local language support in Dutch and French, first-line customer contact, installation, and ongoing support. Clinics receive both devices and AI-powered ECG reports from one trusted partner, simplifying adoption. The partnership was announced on June 27, 2025, and reflects Cardiomatics' strategy to expand through channel partners in new geographic markets. A key milestone under this partnership was the deployment at Clinique Saint-Luc Bouge in Belgium.
• BIOTRONIKcoreChannel Partner/ Reseller/ Distributor · 27 May 2024Cardiomatics announced a partnership with BIOTRONIK, a leading global medical technology company specializing in heart and blood vessel diseases and chronic pain treatments. BIOTRONIK's German sales organization distributes Cardiomatics' AI-powered ECG analysis software alongside its net_ECG advanced ECG-Patch Holter Monitor. The partnership aims to make Cardiomatics' AI solutions more broadly available in Germany by leveraging BIOTRONIK's established presence and expertise in the cardiac rhythm management market. The combined offering is positioned to drive AI adoption in early detection and management of individuals at risk of cardiac events. The partnership was officially announced in May 2024.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• iRhythm Technologies: iRhythm's Zio long-term cardiac monitoring patch combines wearable hardware with a cloud-based AI ECG analysis service (Zio Suite), directly competing with Cardiomatics' Holter analysis platform in ambulatory arrhythmia detection.
• Eko Health: Eko combines AI-powered digital stethoscopes and ECG devices with cloud-based cardiac analysis software (SENSORA) for clinicians, overlapping directly with Cardiomatics' AI ECG interpretation and arrhythmia detection offering.
• AliveCor: AliveCor's KardiaMobile devices and KardiaCloud AI ECG analysis platform target both consumer and clinical arrhythmia detection, comparable to Cardiomatics' clinician-facing Holter AI analysis.

Emerging players

• HeartBeam: HeartBeam develops AI-enabled handheld ECG devices with cloud-based cardiac arrhythmia detection, competing with Cardiomatics in AI-driven ambulatory ECG interpretation, though with a smaller commercial footprint.
• Viz.ai: Viz.ai applies AI to cardiology workflows (e.g., cardiac AI for ECG interpretation) and adjacent clinical areas, partially overlapping with Cardiomatics' AI cardiology positioning and similar AI SaMD regulatory profile.
• Ultromics: Ultromics provides AI-based echocardiography analysis (EchoNous, EchoCore) for cardiology, adjacent to Cardiomatics' ECG analysis but targeting different imaging modalities within the same specialty.

Broad incumbents

• Preventice Solutions (Boston Scientific): Boston Scientific's Preventice portfolio includes BodyGuardian remote cardiac monitors with AI-assisted arrhythmia detection, an established competitor to Cardiomatics in ambulatory Holter/ambulatory ECG monitoring with much larger commercial scale.
• GE Healthcare: GE Healthcare's MUSE cardiology information system and its Holter/ambulatory ECG devices (formerly Getemed, integrated with Cardiomatics' device list) compete with Cardiomatics through bundled hospital-wide ECG management solutions.
• Philips: Philips' IntelliSpace ECG and Holter management portfolio competes with Cardiomatics in hospital-based ECG analysis, leveraging a large installed base across cardiology departments globally.
• Tempus AI: Tempus AI is a broader clinical AI platform with ECG-related applications (via Tempus ECG) and deep cardiology data assets, providing indirect competition and a potential M&A path for Cardiomatics' specialty ECG AI focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/cardiomatics
• Xx.com/cardiomatics

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cardiomatics